Inventor · disambiguated record
Lorna Helen Mitchell
Also filed as: MITCHELL LORNA · MITCHELL LORNA HELEN
54 granted patents·35 pending applications·754 citations·filing 2003–2025
99Inventor score
Files withEPIZYME INC54FORMA THERAPEUTICS INC12BIONOMICS LTD6NOVO NORDISK HEALTHCARE AG6EISAI R&D MAN CO LTD3
Top patents by PatentIndex Score
89 records- 0199US9475776B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Oct 25, 2016·32 cites·9 claims
- 0299US9120757B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 1, 2015·45 cites·36 claims
- 0399US9023883B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 5, 2015·46 cites·20 claims
- 0498US10472371B2Compositions for activating pyruvate kinaseFORMA THERAPEUTICS INC·Filed 2019·Granted Nov 12, 2019·13 cites·3 claims
- 0598US10208052B1Compositions for activating pyruvate kinaseFORMA THERAPEUTICS INC·Filed 2018·Granted Feb 19, 2019·36 cites·10 claims
- 0698US9943504B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Apr 17, 2018·14 cites·17 claims
- 0798US9630961B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Apr 25, 2017·21 cites·24 claims
- 0898US9394258B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jul 19, 2016·39 cites·13 claims
- 0998US9365527B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jun 14, 2016·35 cites·33 claims
- 1098US9133189B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 15, 2015·45 cites·20 claims
- 1197US11980611B2Treating sickle cell disease with a pyruvate kinase R activating compoundNOVO NORDISK HEALTHCARE AG·Filed 2022·Granted May 14, 2024·3 cites·4 claims
- 1297US11844787B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2021·Granted Dec 19, 2023·5 cites·4 claims
- 1397US11649242B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsFORMA THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·5 cites·4 claims
- 1497US11396513B2Compositions for activating pyruvate kinaseFORMA THERAPEUTICS INC·Filed 2020·Granted Jul 26, 2022·6 cites·8 claims
- 1597US11071725B2Activating pyruvate kinase RFORMA THERAPEUTICS INC·Filed 2020·Granted Jul 27, 2021·8 cites·21 claims
- 1697US10675274B2Activating pyruvate kinase RFORMA THERAPEUTICS INC·Filed 2019·Granted Jun 9, 2020·12 cites·13 claims
- 1797US9765035B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 19, 2017·15 cites·14 claims
- 1897US9718816B21-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Aug 1, 2017·25 cites·28 claims
- 1997US9440950B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Sep 13, 2016·34 cites·16 claims
- 2097US9045455B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jun 2, 2015·46 cites·20 claims
- 2196US11014927B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsFORMA THERAPEUTICS INC·Filed 2018·Granted May 25, 2021·6 cites·3 claims
- 2296US10836771B2Compositions for activating pyruvate kinaseFORMA THERAPEUTICS INC·Filed 2019·Granted Nov 17, 2020·7 cites·2 claims
- 2396US9868703B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jan 16, 2018·15 cites·2 claims
- 2496US9732041B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Aug 15, 2017·17 cites·9 claims
- 2596US9598374B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Mar 21, 2017·25 cites·9 claims
- 2696US9447079B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 20, 2016·38 cites·13 claims
- 2796US9346761B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 24, 2016·38 cites·36 claims
- 2896US8952026B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Feb 10, 2015·47 cites·20 claims
- 2994US9724332B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Aug 8, 2017·7 cites·29 claims
- 3093US10081603B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Sep 25, 2018·9 cites·27 claims
- 3192US11905231B1Solid forms, salts and polymorphs of anti-fibrotic compoundsCERTA THERAPEUTICS PTY LTD·Filed 2023·Granted Feb 20, 2024·1 cites·30 claims
- 3292US11185531B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2020·Granted Nov 30, 2021·2 cites·20 claims
- 3392US9776972B2Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Oct 3, 2017·14 cites·31 claims
- 3491US11001588B2Activating pyruvate kinase R and mutants thereofFORMA THERAPEUTICS INC·Filed 2019·Granted May 11, 2021·3 cites·15 claims
- 3591US10227307B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Mar 12, 2019·6 cites·18 claims
- 3691US10039748B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Aug 7, 2018·9 cites·13 claims
- 3790US10632103B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2018·Granted Apr 28, 2020·3 cites·20 claims
- 3890US2024391922A1Pyrrolopyrrole compositions as pyruvate kinase (pkr) activatorsNovo Nordisk Heathcare AG·Filed 2024·Application pending·0 cites
- 3988US12071440B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsNOVO NORDISK HEALTHCARE AG·Filed 2023·Granted Aug 27, 2024·0 cites·4 claims
- 4087US10800743B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2018·Granted Oct 13, 2020·2 cites·20 claims
- 4186US11884673B2Modulators of ion channel receptors and uses thereofBIONOMICS LTD·Filed 2022·Granted Jan 30, 2024·1 cites·16 claims
- 4285US2024182426A1Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2023·Application pending·0 cites
- 4384US12128035B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2022·Granted Oct 29, 2024·1 cites·21 claims
- 4481US10266526B2Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancerEPIZYME INC·Filed 2015·Granted Apr 23, 2019·3 cites·17 claims
- 4579US10179773B2Isoxazole carboxamides as irreversible SMYD inhibitorsEPIZYME INC·Filed 2015·Granted Jan 15, 2019·2 cites·20 claims
- 4678US10577363B2Substituted piperidine compoundsEPIZYME INC·Filed 2015·Granted Mar 3, 2020·2 cites·19 claims
- 4778US7094798B1Inhibitors of checkpoint kinases (Wee1 and Chk1)PFIZER·Filed 2003·Granted Aug 22, 2006·10 cites·9 claims
- 4877US2024262785A1Solid Forms, Salts and Polymorphs of Anti-fibrotic CompoundsCERTA THERAPEUTICS PTY LTD·Filed 2023·Application pending·0 cites
- 4975US12053458B2Treating sickle cell disease with a pyruvate kinase R activating compoundNOVO NORDISK HEALTHCARE AG·Filed 2019·Granted Aug 6, 2024·0 cites·12 claims
- 5075US11384085B2Modulators of ion channel receptors and uses thereofBIONOMICS LTD·Filed 2019·Granted Jul 12, 2022·1 cites·14 claims
Showing the top 50 of 89 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lorna Helen Mitchell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →